- Home
- BARK vs CDXS Comparison
BARK vs CDXS Comparison
Compare BARK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- CDXS
- Stock Information
- Founded
- BARK 2011
- CDXS 2002
- Country
- BARK United States
- CDXS United States
- Employees
- BARK N/A
- CDXS N/A
- Industry
- BARK Department/Specialty Retail Stores
- CDXS Major Chemicals
- Sector
- BARK Consumer Discretionary
- CDXS Industrials
- Exchange
- BARK Nasdaq
- CDXS Nasdaq
- Market Cap
- BARK 244.9M
- CDXS 176.4M
- IPO Year
- BARK N/A
- CDXS 2010
- Fundamental
- Price
- BARK $1.18
- CDXS $2.47
- Analyst Decision
- BARK Buy
- CDXS Buy
- Analyst Count
- BARK 2
- CDXS 2
- Target Price
- BARK $2.50
- CDXS $11.00
- AVG Volume (30 Days)
- BARK 561.9K
- CDXS 532.0K
- Earning Date
- BARK 06-02-2025
- CDXS 05-14-2025
- Dividend Yield
- BARK N/A
- CDXS N/A
- EPS Growth
- BARK N/A
- CDXS N/A
- EPS
- BARK N/A
- CDXS N/A
- Revenue
- BARK $490,256,000.00
- CDXS $59,345,000.00
- Revenue This Year
- BARK $3.12
- CDXS $12.62
- Revenue Next Year
- BARK $7.76
- CDXS $22.11
- P/E Ratio
- BARK N/A
- CDXS N/A
- Revenue Growth
- BARK N/A
- CDXS N/A
- 52 Week Low
- BARK $1.09
- CDXS $1.90
- 52 Week High
- BARK $2.56
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- BARK 44.15
- CDXS 53.65
- Support Level
- BARK $1.09
- CDXS $2.23
- Resistance Level
- BARK $1.15
- CDXS $2.59
- Average True Range (ATR)
- BARK 0.05
- CDXS 0.13
- MACD
- BARK 0.01
- CDXS 0.05
- Stochastic Oscillator
- BARK 57.89
- CDXS 81.82
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.